TRANSITIONAL-CELL CARCINOMA OF THE RENAL PELVIS OR URETER - PATTERNS OF FAILURE

被引:66
作者
COZAD, SC
SMALLEY, SR
AUSTENFELD, M
NOBLE, M
JENNINGS, S
RAYMOND, R
机构
[1] UNIV KANSAS, MED CTR, DEPT RADIAT ONCOL, KANSAS CITY, KS 66103 USA
[2] UNIV KANSAS, MED CTR, DEPT UROL, KANSAS CITY, KS 66103 USA
[3] ST FRANCIS HOSP, DEPT RADIAT ONCOL, TOPEKA, KS USA
关键词
D O I
10.1016/S0090-4295(99)80346-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives. To identify recurrence patterns and possible indications for adjuv Methods. Ninety-four patients with transitional cell carcinoma of the renal pelvis or ureter were reviewed to determine their pattern of failure. Factors including gender and age, tumor stage and grade, and extent of surgical procedure and adjuvant radiation therapy (RT) were analyzed with respect to local and distant recurrence and survival. Results. Seventy-seven patients had resections without residual. On multivariate analysis, grade (P = 0.01) and adjuvant RT (P = 0.02) had significant effects on local control. Metastases were solely dependent on stage (P = 0.0001). Survival was dependent on stage (P = 0.0059) and age (P = 0.036), with the use of adjuvant RT of borderline significance (P = 0.07). Twenty-seven patients were excluded from local failure and survival analysis; of these, 3 died within 1 month of surgery, 5 had metastasis at presentation, and 19 had local disease that was unresectable. Eleven of these 19 were treated by RT, resulting in 2 long-term disease-free survivors after receiving doses of 45 and 50.4 Gy. Conclusions. In patients with adverse factors, such as high grade or stage, close margins, or positive nodes, local control can be improved with adjuvant radiation. Improvement in survival is of borderline significance on multivariate analysis, with approximately 50% of high stage or grade patients developing metastasis.
引用
收藏
页码:796 / 800
页数:5
相关论文
共 13 条
[1]
AFIFI AA, 1979, STATISTICAL ANAL COM
[2]
COMBINATION NEPHROURETERECTOMY AND POSTOPERATIVE RADIOTHERAPY FOR INFILTRATIVE URETERAL CARCINOMA [J].
BABAIAN, RJ ;
JOHNSON, DE ;
CHAN, RC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (09) :1229-1232
[3]
BATATA MA, 1975, CANCER, V35, P1626, DOI 10.1002/1097-0142(197506)35:6<1626::AID-CNCR2820350623>3.0.CO
[4]
2-C
[5]
PRIMARY CARCINOMA OF URETER - A REPORT OF 102 NEW CASES [J].
BLOOM, NA .
JOURNAL OF UROLOGY, 1970, 103 (05) :590-+
[6]
RADIATION THERAPY - A VALUABLE ADJUNCT IN MANAGEMENT OF CARCINOMA OF URETER [J].
BRADY, LW ;
GISLASON, J ;
FAUST, DS ;
KAZEM, I ;
ANTONIADES, J ;
DAVIS, JA .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 206 (13) :2871-+
[7]
THE POSTOPERATIVE IRRADIATION OF TRANSITIONAL CELL-CARCINOMA OF THE RENAL PELVIS AND URETER [J].
BROOKLAND, RK ;
RICHTER, MP .
JOURNAL OF UROLOGY, 1985, 133 (06) :952-955
[8]
COX DR, 1972, J R STAT SOC B, V34, P187
[9]
PROGNOSTIC FACTORS IN CARCINOMA OF THE URETER [J].
HENEY, NM ;
NOCKS, BN ;
DALY, JJ ;
BLITZER, PH ;
PARKHURST, EC .
JOURNAL OF UROLOGY, 1981, 125 (05) :632-636
[10]
HOLLANDER M, 1973, NONPARAMETRIC STATIS